Luseogliflozin, a sodium-glucose cotransporter-2 inhibitor, reverses cerebrovascular dysfunction and cognitive impairments in 18-mo-old diabetic animals

Shaoxun Wang, Feng Jiao, Jane J. Border, Xing Fang, Reece F. Crumpler, Yedan Liu, Huawei Zhang, Joshua Jefferson, Ya Guo, Parker S. Elliott, Kirby N. Thomas, Luke B. Strong, Austin H. Urvina, Baoying Zheng, Arjun Rijal, Stanley V. Smith, Hongwei Yu, Richard J. Roman, Fan Fan

Research output: Contribution to journal › Article › peer-review